Vicarious Surgical Inc.

$ 3.30

26.92%

03 Dec - close price

  • Market Cap 21,609,300 USD
  • Current Price $ 3.30
  • High / Low $ 3.66 / 2.65
  • Stock P/E N/A
  • Book Value 2.36
  • EPS -9.03
  • Next Earning Report -
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.63 %
  • ROE -1.49 %
  • 52 Week High 18.97
  • 52 Week Low 2.44

About

None

Analyst Target Price

$5.00

Quarterly Earnings

Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
Reported Date 2025-11-132025-08-122025-04-282025-03-032024-11-122024-08-122024-04-292024-03-042023-11-132023-07-272023-05-082023-02-13
Reported EPS -1.91-2.23-2.58-2.43-2.87-2.59-0.1-0.06-0.1-0.12-0.21-0.09
Estimated EPS -2.3267-0.14-2.48-2.69-2.55-2.77-0.09-0.12-0.14-0.14-0.13-0.17
Surprise 0.4167-2.09-0.10.26-0.320.18-0.010.060.040.02-0.080.08
Surprise Percentage 17.9095%-1492.8571%-4.0323%9.6654%-12.549%6.4982%-11.1111%50%28.5714%14.2857%-61.5385%47.0588%

Next Quarterly Earnings

Reported Date
Fiscal Date Ending
Estimated EPS
Currency

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: RBOT

Vicarious Surgical Announces Launch of Proposed Public Offering

2023-08-02 16:45:00

Vicarious Surgical Inc. announced the commencement of an underwritten public offering of $45.0 million of its Class A common stock, with an option for underwriters to purchase an additional $6.75 million. The company plans to use the net proceeds, along with existing cash, to fund ongoing operations, including the development of its single-port surgical robot, the Vicarious Surgical System, and for general corporate purposes. Morgan Stanley & Co. LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering.

Jeffrey Scott Obituary (1978 - 2022) - Foxborough, MA - Sun Chronicle

2022-01-19 18:16:56

Jeffrey R. Scott, PhD, age 43 of Foxborough, passed away on Friday, January 14, 2022. He was a devoted husband and father, and had a significant career in the Medical Device industry, most recently as Director of Clinical Engineering at Vicarious Surgical, Inc., and also served as an Adjunct Professor at Brown University. The obituary details his life, career, family, and funeral arrangements, including a donation fund in his memory.

Vicarious Surgical wins FDA breakthrough designation for surgical robot

2019-12-05 01:11:29

Vicarious Surgical announced it received FDA breakthrough device designation for its virtual reality-based robot-assisted surgical device. The company claims its technology allows surgeons to perform minimally invasive procedures through a single micro-incision, effectively "shrinking the surgeon and putting them inside the patient." This designation validates the platform and its clinical value, supporting its path toward commercialization.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi